Lanthionine synthetase component C-like protein 2 (LANCL2) is a member of the LANCL
protein family, which is broadly expressed throughout the body. LANCL2 is the molecular …

Established LANCL2 agonists such as abscisic acid (ABA) and NSC61610 exert anti-
inflammatory activity in a broad range of diseases models ranging from IBD to dia betes and …

Background Lanthionine synthetase component C-like protein 2 (LANCL2) is a member of
the eukaryotic lanthionine synthetase component C-Like protein family involved in signal …

Lanthionine synthetase C-like 2 (LANCL2), a novel therapeutic target for inflammatory and
autoimmune diseases and diabetes, exerts anti-inflammatory and insulin-sensitizing effects …

The rates of type 2 diabetes (T2D) are rising to epidemic proportions in the US and
worldwide. While current T2D medications are efficacious, significant side effects have …

Lanthionine synthetase component C-like protein 2 (LANCL2) has been identified as the
mammalian receptor mediating the functional effects of the universal stress hormone …

Lanthionine synthetase C-like 2 (LANCL2) therapeutics have gained increasing recognition
as a novel treatment modality for a wide range of autoimmune diseases. Genetic ablation of …

The lanthionine synthetase C-like (LANCL) proteins include LANCL2, which is expressed in
the central nervous system (CNS) and in peripheral tissues. LANCL2 exhibits …

Prostate cancer (PCa) is the most commonly diagnosed malignancy in male. Numerous
studies have focused on the molecular mechanisms of carcinogenesis and progression …

Abstract LANCL1 (LanC-like protein 1) is related to the bacterial LanC (lanthionine
synthetase C) family, which is involved in the biosynthesis of antimicrobial peptides. Highest …